WO2003002200A1 - Apparatus for physiotherapic hyperthermia treatments - Google Patents

Apparatus for physiotherapic hyperthermia treatments Download PDF

Info

Publication number
WO2003002200A1
WO2003002200A1 PCT/EP2002/007118 EP0207118W WO03002200A1 WO 2003002200 A1 WO2003002200 A1 WO 2003002200A1 EP 0207118 W EP0207118 W EP 0207118W WO 03002200 A1 WO03002200 A1 WO 03002200A1
Authority
WO
WIPO (PCT)
Prior art keywords
temperature
tes
area
heat
source
Prior art date
Application number
PCT/EP2002/007118
Other languages
French (fr)
Inventor
Fabio Ricci
Antonello Borrani
Original Assignee
Easytech S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Easytech S.R.L. filed Critical Easytech S.R.L.
Publication of WO2003002200A1 publication Critical patent/WO2003002200A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/02Radiation therapy using microwaves
    • A61N5/04Radiators for near-field treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00084Temperature
    • A61B2017/00092Temperature using thermocouples
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001Body part
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0054Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0088Radiating heat

Definitions

  • the invention belongs to the sector that includes the apparatuses for physiotherapic treatments through hyperthermia.
  • hypothermia has been more and more tightly associated to the concepts of great effectiveness of deep- reaching heat and of high accuracy in the determination of the temperature and distribution of such a heat.
  • an apparatus designed to induce hyperthermia for therapeutic purposes shall include, among its other functions and devices, a system for the measurement of temperature which is extremely accurate and more or less complex, depending on the specific objective of the intended therapy.
  • hyperthermia can be defined as "the heat therapy able to treat the involved tissues in the small temperature interval in which heat has a healing effect that helps to achieve physical rehabilitation".
  • the mentioned interval is the one between the limit temperatures of 37 and 45.5°C, and that, normally, a much smaller interval is used that is specific for the area to be treated and for the involved pathology.
  • the conventional heat therapies applicable are far from meeting the requirement mentioned above - the treatment temperature varies over a wide range of almost random values and, therefore, the apparatuses used for them cannot be included among those specific for hyperthermia.
  • an already well tested and validated method to obtain an effective heating consists of the concurrent local application of endogenous heat having a high penetration depth and exogenous heat having highly stabilizing power on the surface of the part to be treated.
  • the endogenous heat is generated by electromagnetic waves at a frequency of 434 MHz, the exogenous heat through a thermo-regulated fluid that is circulated in a thin-walled bag that is put in contact with the area to be treated.
  • Control of the heat sources is obtained through temperature measurements made by a suitable number of sensors installed in the correct positions, which are sufficiently independent to provide adequate control of each of the two heat sources.
  • the sensors must be of the non-invasive type, because invasive type sensors are unacceptable as far as physiotherapy is concerned.
  • the two temperature measurements that meet the specified requirements are those related to the temperature of the interface between the skin and the bag that contains the thermo-regulated fluid (bolus) - at the point of maximum electromagnetic radiation - and the temperature of the fluid. It can be demonstrated, both theoretically and experimentally, that they are sufficiently independent to permit control of the two sources, provided that their values are known with sufficient accuracy.
  • the first purpose of this invention is, therefore, to achieve better control -both in terms of accuracy and reliability - of the temperature that is attained in the deeper layers of tissue during the application of physiotherapic hyperthermia treatment.
  • the second purpose is to obtain such an accuracy at a limited cost so as to achieve a widespread adoption of physioterapic hyperthermia made by use of dual heat source apparatuses - an endogenous source to heat the deep-laying tissues and an exogenous source for surface temperature control.
  • FIG. 1 shows the schematic diagram of an apparatus intended for physiotherapic hyperthermia treatment
  • Fig. 2 shows a schematics of the conventional temperature measuring system of an apparatus as the one shown in Fig. 1 ;
  • - Fig.3 shows a schematics of the temperature measuring system as the one installed in an apparatus as invented.
  • Any conventional physiotherapic hyperthermia apparatus includes an endogenous heat source (1 ), and an exogenous heat source (2). Both heat sources are managed through an electronic controller (4) that uses, as a feedback, the temperature measurements sent by a thermometer made up of electronic circuits (3A), that you can see in Fig. 1 , and a sensor (3B) that you can see in Fig. 2. Another thermometer still made of electronic circuits (6A) that you can see in Fig.1 and a sensor (6B), also shown in Fig. 2, complete the system.
  • source (2) consists of a thermo-regulated fluid module the temperature of which is controlled by controller (4) through the thermometer (3A, 3B).
  • Source number 1 consists of an electromagnetic wave generator that generates electromagnetic waves at the approximate frequency of 434 MHz which go through an applicator (9) and reach area (S) of the patient's body.
  • the applicator is a "Ridged Horn” antenna with the bag (5) in which the thermo-regulated fluid transparent to the working frequency circulates, integrated.
  • a temperature sensor (6B) is located between the applicator (9) and the area to be treated.
  • the temperature sensor (6B) which is shown in detail in figure 2, gives the "skin" temperature.
  • sensor 6B is a normal thermocouple.
  • a temperature sensor (8) of the type fitted to the invented apparatus includes two type T (copper - constantan) thermocouples having junctions G1 and G2, the first of which is placed at the interface between the bag (5) and the patient's body, and the second is in thermal contact with the thermo-regulated fluid of the exogenous source (2).
  • T copper - constantan
  • thermocouples At terminals M1 and M2 it is thus possible to measure a voltage proportional to the difference between the temperatures sensed by junctions G1 and G2.
  • An advantage given by the type of used thermocouples is that two copper wires reach terminals M1 and M2. In this way extraneous thermo-electrical phoenomena occurring at the two terminals are negligible.
  • the fluid temperature is measured by use of an absolute sensor (3B), that also permits the results of the differential measurements to be tranformed in absolute values whenever required. From the above, the advantages offered by the selection of the absolute fluid temperature as the first temperature measurement become quite evident.
  • This temperature is measured by the same sensor that provides its thermo-regulation.
  • the difference between the temperature of the bag and bag-skin interface is obtained by placing a G1 thermocouple at the interface, and a G2 thermocouple (reference junction) in tight thermal contact with the fluid.
  • reference junction G2 is installed where the fluid enters the bag (5).
  • the measurement point is the ideal one for this purpose because it is the closest possible to the actual temperature of the fluid contained in the bag.
  • the invention also features a method for temperature control in applications related to physioterapic hyperthermia, which is based preferably on the devices that were described above.
  • the following phases apply:
  • the apparatus operates in a temperature interval optimized for physiotherapic hyperthermia, therefore a higher accuracy is obtained as far as the estimated internal temperature distribution, and, in consequence, the control of the hyperthermia treatment are concerned, at the same costs and with equivalent means.
  • the mentioned feature is even more important when it is necessary to heat the tissues up only to a very limited extent, that is, when scarcely blood supplied tissues are to be treated. This because, in such cases, the ⁇ T required and to be controlled is very small, and, consequently, an error in the measurements has a greater negative impact on the effectiveness of the treatment.
  • the peculiar effectiveness, ease of application and use of the apparatus that is the subject of the invention are further evident in the above cases.

Abstract

Apparatus for physiotherapic hyperthermia treatments comprising: - one endogenous heat source (1) and one exogenous heat source (2), both sources being under controlled temperatures (Tes and Ts); - means to apply heat to an area (S) of the patient's skin that corresponds to the part of the body to be treated; the heat is applied as a result of control input signals; - means to control the temperature (Tt) of the body part to be treated, which is attained in consequence of the application of heat. Temperature control shall be achieved as a function of at least temperature (Ts) of the skin area (S) and of Tes. The temperature control means indicated include the means for direct measurement of the temperature difference Δ(Tes-Ts) between the temperature of the exogenous heat source and the temperature of the skin area (S).

Description

APPARATUS FOR PHYSIOTHERAPIC HYPERTHERMIA TREATMENTS Area of Applicability of The Invention
The invention belongs to the sector that includes the apparatuses for physiotherapic treatments through hyperthermia.
As known, at least since the Seventies, the word "hyperthermia" has been more and more tightly associated to the concepts of great effectiveness of deep- reaching heat and of high accuracy in the determination of the temperature and distribution of such a heat.
As a result, an apparatus designed to induce hyperthermia for therapeutic purposes shall include, among its other functions and devices, a system for the measurement of temperature which is extremely accurate and more or less complex, depending on the specific objective of the intended therapy. Nowadays, hyperthermia can be defined as "the heat therapy able to treat the involved tissues in the small temperature interval in which heat has a healing effect that helps to achieve physical rehabilitation".
It is also known that the mentioned interval is the one between the limit temperatures of 37 and 45.5°C, and that, normally, a much smaller interval is used that is specific for the area to be treated and for the involved pathology. In general, the conventional heat therapies applicable are far from meeting the requirement mentioned above - the treatment temperature varies over a wide range of almost random values and, therefore, the apparatuses used for them cannot be included among those specific for hyperthermia. State of the art
Currently, an already well tested and validated method to obtain an effective heating consists of the concurrent local application of endogenous heat having a high penetration depth and exogenous heat having highly stabilizing power on the surface of the part to be treated. The endogenous heat is generated by electromagnetic waves at a frequency of 434 MHz, the exogenous heat through a thermo-regulated fluid that is circulated in a thin-walled bag that is put in contact with the area to be treated. Control of the heat sources is obtained through temperature measurements made by a suitable number of sensors installed in the correct positions, which are sufficiently independent to provide adequate control of each of the two heat sources. Also, the sensors must be of the non-invasive type, because invasive type sensors are unacceptable as far as physiotherapy is concerned.
The two temperature measurements that meet the specified requirements are those related to the temperature of the interface between the skin and the bag that contains the thermo-regulated fluid (bolus) - at the point of maximum electromagnetic radiation - and the temperature of the fluid. It can be demonstrated, both theoretically and experimentally, that they are sufficiently independent to permit control of the two sources, provided that their values are known with sufficient accuracy.
An apparatus of this type is described in Italian patent IT01247029. Yet, the already known apparatuses have some limitations as to the accuracy of the measurement of the temperature of the skin at the bolus bag interface which are linked to the control of the endogenous source. Such limitations have an impact on the control of the treatment, and, consequently, on the quality of the therapy. Purpose of the invention The first purpose of this invention is, therefore, to achieve better control -both in terms of accuracy and reliability - of the temperature that is attained in the deeper layers of tissue during the application of physiotherapic hyperthermia treatment.
The second purpose is to obtain such an accuracy at a limited cost so as to achieve a widespread adoption of physioterapic hyperthermia made by use of dual heat source apparatuses - an endogenous source to heat the deep-laying tissues and an exogenous source for surface temperature control.
Summary of the invention
To achieve the specified purposes, an apparatus for physiotherapic hyperthermia has been realized, according to the main claim described herein. Additional advantages are obtained through the solutions subject of the secondary claims.
List of drawings
The mentioned and other additional advantages will be more clearly understood by any technician specialized in the field basing on the following description and the attached drawings provided as examples. The drawings shall not be considered as binding.
- Fig. 1 shows the schematic diagram of an apparatus intended for physiotherapic hyperthermia treatment;
- Fig.2 shows a schematics of the conventional temperature measuring system of an apparatus as the one shown in Fig. 1 ;
- Fig.3 shows a schematics of the temperature measuring system as the one installed in an apparatus as invented.
Detailed description Ref. Fig. 1. Any conventional physiotherapic hyperthermia apparatus includes an endogenous heat source (1 ), and an exogenous heat source (2). Both heat sources are managed through an electronic controller (4) that uses, as a feedback, the temperature measurements sent by a thermometer made up of electronic circuits (3A), that you can see in Fig. 1 , and a sensor (3B) that you can see in Fig. 2. Another thermometer still made of electronic circuits (6A) that you can see in Fig.1 and a sensor (6B), also shown in Fig. 2, complete the system. As an example, source (2) consists of a thermo-regulated fluid module the temperature of which is controlled by controller (4) through the thermometer (3A, 3B). The fluid is circulated within a bag (5) that is placed on an area (S) of the patient's body. Source number 1 consists of an electromagnetic wave generator that generates electromagnetic waves at the approximate frequency of 434 MHz which go through an applicator (9) and reach area (S) of the patient's body. In the described case, the applicator is a "Ridged Horn" antenna with the bag (5) in which the thermo-regulated fluid transparent to the working frequency circulates, integrated.
A temperature sensor (6B) is located between the applicator (9) and the area to be treated. The temperature sensor (6B) which is shown in detail in figure 2, gives the "skin" temperature. In the case of figure 2, sensor 6B is a normal thermocouple. By referring to figure 3, it can be observed that, in this invention, and different from the conventional apparatuses (Fig. 2) which use separate temperature measuring channels for each measurement point, the apparatus is fitted with a sensor (8) which is specialized for the accurate and direct measurement of the difference between the temperature of the fluid of the exogenous source and the skin temperature measured at the interface between the bag (5) and the area to be treated (S). Still by referring to figure 3, a temperature sensor (8) of the type fitted to the invented apparatus includes two type T (copper - constantan) thermocouples having junctions G1 and G2, the first of which is placed at the interface between the bag (5) and the patient's body, and the second is in thermal contact with the thermo-regulated fluid of the exogenous source (2).
At terminals M1 and M2 it is thus possible to measure a voltage proportional to the difference between the temperatures sensed by junctions G1 and G2. An advantage given by the type of used thermocouples is that two copper wires reach terminals M1 and M2. In this way extraneous thermo-electrical phoenomena occurring at the two terminals are negligible.
The fluid temperature is measured by use of an absolute sensor (3B), that also permits the results of the differential measurements to be tranformed in absolute values whenever required. From the above, the advantages offered by the selection of the absolute fluid temperature as the first temperature measurement become quite evident. This temperature is measured by the same sensor that provides its thermo-regulation. The difference between the temperature of the bag and bag-skin interface is obtained by placing a G1 thermocouple at the interface, and a G2 thermocouple (reference junction) in tight thermal contact with the fluid. In a preferred design, reference junction G2 is installed where the fluid enters the bag (5). In this case, if a relatively fast circulation of the fluid is selected, the fluid flowing out of the bag to return to the thermo-regulation module is still nearly (tolerance is approx. 0.1 °C) at the same temperature as when it flowed into the bag. This means that the measurement point is the ideal one for this purpose because it is the closest possible to the actual temperature of the fluid contained in the bag.
The invention also features a method for temperature control in applications related to physioterapic hyperthermia, which is based preferably on the devices that were described above. The following phases apply:
- determination of the temperature (T1) that must be attained in the treatment area;
- application of heat in the skin area (S) that corresponds to the body part to treat. This is achieved by use of an endogenous, radio-frequency heat source; - heating of the skin area (S) of the body part to be treated by use of an exogenous controlled and constant temperature (Tes) heat source;
- direct measurement of temperature difference Δ(Tes-Ts) between Tes and skin temperature Ts in area (S).
- calculation of temperature Tt of the area to be treated, as a function of Δ(Tes- Ts) and Tes;
- adjustment of electromagnetic energy emission from the endogenous source as a function of the measured and estimated temperatures.
Example of application
A comparison between the operation of the apparatus as invented and that of a conventional type apparatus is detailed hereafter. The following has to be taken into account: a) Errors affecting the measurements of the fluid and of the skin temperature in a way that the measurement of the difference between the two temperatures is correct, are transferred approximately unchanged on the estimated maximum internal temperature. As an example, a 1 °C error both on the fluid and on the skin temperature measurements (errors must have the same sign) will result in an error of approximately 1°C affecting the estimated maximum internal temperature; b) An error affecting the measurement of the difference between the fluid temperature and the skin temperature is transferred, approximately doubled, on the estimated maximum internal temperature. This means, for instance, that a 1°C error on the measurement of the difference between the fluid temperature and the skin temperature will result in an error of approximately 2°C on the estimated maximum internal temperature. Let's assume now (case "a") that the error concerning the fluid temperature is negligible - this is possible if the temperature measuring circuit and the hydraulic circuit are correctly designed and built - and the error concerning the temperature measured by the skin thermocouple G1 is +0.5 or -0.5°C.
(Note that the above mentioned error is the typical tolerance applicable to most of the modules that are available commercially and described in the applicable literature, and the reasons for this are two: First it is difficult to obtain the necessary thermal coupling between the reference junction and the absolute correction sensor on a printed circuit board, and, second, higher performance levels are not usually required). This means that, if you select, for instance, a ΔT = 0 the control circuit (4) may read ΔT = +0.5°C or ΔT = -0.5°C, corresponding to very different electromagnetic energy emission levels (the difference may range from 0 to a few tens of Watt). In the area of maximum temperature inside the patient's body, where the error is approximately twice as much, there can be an error of ± 1 °C with respect to the desired value. Since a further 1 °C error can be expected due to factors that cannot be controlled and are independent of the apparatus, it may happen that a treatment suitable for muscle tissues is carried out instead of the intended treatment optimized for connective tissues, or vice versa. This, obviously, makes the patient's recovery time longer. Conversely, (case "b") if ΔT is measured directly by use of the apparatus according to the invention, the error concerning ΔT will be extremely small, e.g. not greater than 0.15°C, all other conditions remaining unchanged. Therefore, the treatments will be much more accurate, and it will be possible to carefully select the types of tissues to treat. Advantageously, the apparatus operates in a temperature interval optimized for physiotherapic hyperthermia, therefore a higher accuracy is obtained as far as the estimated internal temperature distribution, and, in consequence, the control of the hyperthermia treatment are concerned, at the same costs and with equivalent means. It is to be highlighted that the mentioned feature is even more important when it is necessary to heat the tissues up only to a very limited extent, that is, when scarcely blood supplied tissues are to be treated. This because, in such cases, the ΔT required and to be controlled is very small, and, consequently, an error in the measurements has a greater negative impact on the effectiveness of the treatment. The peculiar effectiveness, ease of application and use of the apparatus that is the subject of the invention are further evident in the above cases. From what described above, it is clear that, given that it is important to keep the temperature measurement errors as small as possible, it is essential to take a particularly good care of the accuracy of the measurement of the difference between the two temperatures, rather than of the accuracy of each individual temperature measurement. This is the innovative feature of the invention covered herein.
The invention has been described with reference to preferred implementation solutions, but it is to be understood that any technician expert in the field will be able to embody equivalent modifications without the rights bestowed according to the claimed patent being voided.

Claims

1. Apparatus for physiotherapic hyperthermia treatments, comprising:
- an endogenous heat source (1) and an exogenous heat source (2); both sources being under controlled temperatures (Tes and Ts); - means to apply such a heat under controlled input to an area (S) of the patient's skin corresponding to a part of the patient's body to be treated;
- means to control the temperature (Tt) of the body part to be treated, which is attained as a result of the application of the mentioned heat, as a function of at least the temperature (Ts) of such an area (S) and of Tes, characterized in that said control means include means for the direct measurement of the difference Δ(Tes-Ts) between the temperature of the exogenous source and the temperature of the skin in the area (S) to be treated.
2. Apparatus according to claim 1 , wherein the said means for the measurement of Δ(Tes-Ts) consist of a single temperature measuring module (8) comprising two electrically connected thermocouples (G1 , G2), the first sensing the temperature in area (S), and the second in thermal contact with the exogenous temperature- controlled heat source (2).
3. Apparatus according to claim 2, where:
- the source (2) consists of a module containing thermo-regulated fluid that is circulated through a bag-type applicator (5) designed to be placed on the area to be treated (S);
- the source (1 ) consists of an approx. frequency of 434 MHz electromagnetic wave generator that emits waves that reach area (S) from the applicator (9) and the bag (5); - temperature Tes is measured by an absolute sensor (3); - said means to control the temperature (Tt) include a controller (4), that receives a value (Tes) from sensor (3), a value Δ(Tes-Ts) from module (8), and a unit that computes Tt as a function of Δ(Tes-Ts) and Tes, as well as means to control the emission of electromagnetic energy by the endogenous source (1 ) as a function of the measured and estimated temperature values.
4. Apparatus according to claim 3, characterized in that the reference junction (G2) is installed in proximity of the point where the fluid enters the bag (5).
5. Method for temperature control in case of physiotherapic hyperthermia treatments comprising the following steps: - determination of the correct temperature (Tt) to be obtained in the treatment area;
- application of heat in the skin area (S) corresponding to the body part to be treated by use of a radio-frequency endogenous source;
- application of heat in the skin area (S) by use of an exogenous source under constant, controlled temperature (Tes); characterized in that it comprises also the following steps:
- direct measurement of the temperature difference Δ(Tes-Ts) between (Tes) and the skin temperature in area (S), (Ts).
- calculation of the temperature (Tt) attained in the area to be treated by application of heat, as a function of Δ(Tes-Ts) and (Tes);
- regulation of the electromagnetic energy emitted by the endogenous source as a function of the measured and estimated temperature values.
6. Method according to claim 5, wherein said endogenous heat source operates at a frequency included in the ISM (Industrial, Scientific, Medical) interval the central value of which is 433. 920 MHz.
7. Method according to claim 5, wherein said measurement of Δ(Tes-Ts) is performed through a temperature measuring module including thermocouples.
8. Method according to claim 5, wherein said temperature (Tes) is comprised in the range from 20 C° to 50 C°.
9. Method according to claim 5, wherein said temperature (T1) is comprised in the range from 37 C° to 46 C°.
10. Sensor for the measurement of the induced temperature in physiotherapic hyperthermia treatments comprising two heat sources - one endogenous and the other exogenous characterized in that such sensor comprises means for directly measuring the temperature difference Δ(Tes-Ts) between the temperature of the exogenous heat source (Tes) and the skin temperature (Ts) obtained in area (S) as a result of the application of both exogenous and endogenous heat.
11. Sensor according to claim 10, wherein said means comprise two thermocouples (G1 , G2) in electrical contact, the first being in thermal contact with area (S), the second being in thermal contact with the exogenous heat source (2) under controlled temperature (Tes).
PCT/EP2002/007118 2001-06-28 2002-06-27 Apparatus for physiotherapic hyperthermia treatments WO2003002200A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITF12001A000118 2001-06-28
IT2001FI000118A ITFI20010118A1 (en) 2001-06-28 2001-06-28 EQUIPMENT FOR PHYSIOTHERAPY HYPERTHERMIA TREATMENTS

Publications (1)

Publication Number Publication Date
WO2003002200A1 true WO2003002200A1 (en) 2003-01-09

Family

ID=11442225

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/007118 WO2003002200A1 (en) 2001-06-28 2002-06-27 Apparatus for physiotherapic hyperthermia treatments

Country Status (2)

Country Link
IT (1) ITFI20010118A1 (en)
WO (1) WO2003002200A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089466A1 (en) * 2003-04-10 2004-10-21 Bonsegna, Pier, Luigi, Maria Apparatus for non-destructive hyperthermia therapy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003823A1 (en) * 1986-11-28 1988-06-02 Bsd Medical Corporation Hyperthermia apparatus
EP0519415A1 (en) * 1991-06-19 1992-12-23 SMA SEGNALAMENTO MARITTIMO ED AEREO S.p.A. Microwave apparatus for clinical hyperthermia in endogenous thermotherapy
US6162184A (en) * 1994-06-27 2000-12-19 Ep Technologies, Inc. Systems and methods for sensing temperature within the body

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003823A1 (en) * 1986-11-28 1988-06-02 Bsd Medical Corporation Hyperthermia apparatus
EP0519415A1 (en) * 1991-06-19 1992-12-23 SMA SEGNALAMENTO MARITTIMO ED AEREO S.p.A. Microwave apparatus for clinical hyperthermia in endogenous thermotherapy
IT1247029B (en) 1991-06-19 1994-12-12 S M A Segnalamento Marittimo E MICROWAVE EQUIPMENT FOR CLINICAL HYPERTHERMIA IN ENDOGENIC THERMOTHERAPY
US6162184A (en) * 1994-06-27 2000-12-19 Ep Technologies, Inc. Systems and methods for sensing temperature within the body

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089466A1 (en) * 2003-04-10 2004-10-21 Bonsegna, Pier, Luigi, Maria Apparatus for non-destructive hyperthermia therapy

Also Published As

Publication number Publication date
ITFI20010118A1 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
EP0278177B1 (en) Method and apparatus for measuring oxygen partial pressure and temperature in living tissue
Bruggmoser et al. Quality assurance for clinical studies in regional deep hyperthermia
EP1753357B1 (en) Radiofrequency ablation with independently controllable ground pad conductors
Dewhirst et al. RTOG quality assurance guidelines for clinical trials using hyperthermia
US4860752A (en) Invasive microwave array with destructive and coherent phase
Sherar et al. Comparison of thermal damage calculated using magnetic resonance thermometry, with magnetic resonance imaging post-treatment and histology, after interstitial microwave thermal therapy of rabbit brain
US20170215940A1 (en) Control and delivery of electric fields via an electrode array
KR20040015257A (en) Magnetic resonance system and method for operating the same
CN102149352A (en) A safe skin treatment apparatus for personal use and method for its use
Carnochan et al. The practical use of thermocouples for temperature measurement in clinical hyperthermia
Vogl et al. MR‐based thermometry of laser induced thermotherapy: temperature accuracy and temporal resolution in vitro at 0.2 and 1.5 T magnetic field strengths
van Vulpen et al. Prostate perfusion in patients with locally advanced prostate carcinoma treated with different hyperthermia techniques
CN108720838A (en) Estimate tissue thickness using conduit temperature rate of change
Samaras Intracranial microwave hyperthermia: heat induction and temperature control
Kowalski et al. Model-based optimization of phased arrays for electromagnetic hyperthermia
WO2003002200A1 (en) Apparatus for physiotherapic hyperthermia treatments
CN101854877A (en) Apparatus and methods for the positioning of implantable leads
Samulski et al. Thermometry in therapeutic hyperthermia
NL8500765A (en) METHOD AND APPARATUS FOR NON-INVASIVE, CONTACT-FREE, HYPER-THERMAL DESTRUCTION OF TUMORS AND THE LIKE.
WO2020247208A1 (en) Assessment of skin perfusion using microwave heating and using infrared radiometry
Lee et al. Influence of water bolus temperature on measured skin surface and intradermal temperatures
Astrahan et al. The accuracy of temperature measurement from within an interstitial microwave antenna
Ryan Methods of thermal modeling and their impact on interstitial hyperthermia treatment planning
Mazokhin et al. A HFEM installation allowing simultaneous whole body and deep local EM hyperthermia
Cetas et al. Physics today, clinic tomorrow. A plan for new system development

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG US

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP